Skip to main content
. 2021 Dec 13;6:412. doi: 10.1038/s41392-021-00823-w

Fig. 5. Schematic illustration of TCR-based immunotherapy.

Fig. 5

T cells are isolated from the patient’s cancer tissue or peripheral blood and genetically modified by retroviral transduction to express antigen-specific TCR or CAR on T cells. Cells are then expanded ex vivo until sufficient cell numbers are achieved and reinfused into the patient’s body, where they can fight cancer cells.